Nosca-Méréprine (Noscapine Hydrochloride Monohydrate)

Noscapine hydrochloride acts on the central nervous system, likely by antagonizing sigma‑1 receptors and modulating cough‑related neurotransmission in the brainstem, which reduces the cough reflex without the opioid‑related side effects.

The appropriate dose of Nosca-Méréprine is determined by the prescribing healthcare professional based on the patient’s age, weight, and severity of cough. Patients should follow the prescriber’s instructions and the product label.

Safety data for noscapine hydrochloride in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike opioid‑based cough medicines, noscapine provides antitussive relief without significant risk of dependence or respiratory depression. It is generally considered safer for short‑term use, though efficacy may be comparable for dry cough relief.

Store Nosca-Méréprine at ambient temperature below 25 °C, in its original packaging, and protect it from moisture and direct sunlight. Keep out of reach of children and do not use after the expiry date.

Nosca-Méréprine is taken orally, usually as a tablet or liquid preparation, as directed by the prescriber. It should be swallowed with water and not chewed unless the formulation specifically allows it.

Serious risks, though rare, include allergic reactions such as rash, angioedema, or severe skin conditions like Stevens‑Johnson syndrome, as well as possible liver enzyme elevations. Any signs of hypersensitivity require immediate medical attention.

Individuals with known hypersensitivity to noscapine or any component of the formulation should avoid using Nosca-Méréprine. It is also contraindicated in patients where cough suppression could mask serious underlying conditions without medical supervision.